FFCP PHASE1:Hg19::chr17:6745896..6745904,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr17:6745896..6745904,- | |||
|coexpression_cluster_id=C110 | |||
|description=CAGE_peak_at_chr17:6745896..6745904,- | |||
|id=chr17:6745896..6745904,- | |||
|ontology_enrichment_celltype=CL:0000817!6.63e-16!3;CL:0002327!1.54e-11!4;CL:0000785!2.09e-11!2;CL:0000955!2.09e-11!2;CL:0000818!2.09e-11!2;CL:0000954!2.09e-11!2;CL:0000816!2.09e-11!2;CL:0000037!2.30e-08!172;CL:0000566!2.30e-08!172;CL:0002032!6.34e-08!165;CL:0000837!6.34e-08!165;CL:0000988!1.16e-07!182;CL:0000945!3.78e-07!24;CL:0000826!3.78e-07!24 | |||
|ontology_enrichment_celltype_v019=CL:0000763;5.41e-09;100!CL:0000097;6.21e-07;5 | |||
|ontology_enrichment_celltype_v019_2=CL:0000763,1.35e-09,108;CL:0000049,1.35e-09,108;CL:0000097,6.77e-07,5;CL:0002028,6.77e-07,5 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:2531!2.05e-22!51;DOID:0060083!2.05e-22!51;DOID:1240!1.03e-16!39;DOID:8692!3.69e-15!31;DOID:162!5.18e-13!235;DOID:14566!1.31e-12!239;DOID:0060058!1.50e-12!10;DOID:1036!6.58e-11!8;DOID:0050686!4.94e-08!137;DOID:8552!8.34e-07!1;DOID:3111!9.81e-07!1;DOID:3603!9.81e-07!1 | |||
|ontology_enrichment_disease_v019=DOID:1036;1.50e-32;8!DOID:8552;1.33e-29;1!DOID:3111;2.73e-29;1!DOID:3603;2.73e-29;1!DOID:8692;4.36e-23;31!DOID:1240;1.94e-13;39!DOID:2531;7.03e-09;51!DOID:0060083;7.03e-09;51 | |||
|ontology_enrichment_disease_v019_2=DOID:1036,1.42e-32,8;DOID:8552,1.33e-29,1;DOID:3111,3.16e-29,1;DOID:3603,3.16e-29,1;DOID:8692,3.34e-23,31;DOID:1240,1.54e-18,39;DOID:2531,2.83e-14,51;DOID:0060083,2.83e-14,51 | |||
|ontology_enrichment_uberon=UBERON:0001911!1.54e-11!4;UBERON:0005333!1.54e-11!4;UBERON:0008425!1.54e-11!4;UBERON:0005311!1.54e-11!4 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.309868802321207,0.426507697462265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0895585227028483,0,0.383382679165211,0,0,0,1.00883967391873,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.106727557803444,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.144269212976445,0,0,0,0,0,0,0,0.228234679033192,0,0,0,0,0.201799707191048,0,0.343505344755765,0,0,0,0,0,1.23087398947712,0,0.99921590399346,0,0,0,0,0.111443384277478,0,0,0,0,0,0,0,0.16480387422676,0,0,0,0,0,0,0,0.269605053441981,0,0,0,0,0,0,0,0,0,0.0874599999961957,0,0.227586896570999,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.82559859230266,0.225595660617181,0,0,1.13852239634511,3.97341447450947,0,0,0,0,0,0,0,0,0,0,0,0,0,0.547364367646998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0967563312890851,0,0,0,0,0,0.137041924646751,0,0,0,0.160317640503067,0,0.19980960958213,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.03017728242729,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.606596470166591,0,0,0,0,0,0,0,0,0,0,0,0,0,0.147855149989634,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.05656061679314,0,0.106691729694141,0,0,0,0,0,0,0,0.314531883711793,0,0,0.212574920101683,0.123935764259002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.115525666150338,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.230467975111559,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4226557275834,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.112131862580613,0,0,0,0,0,0,0,0.325613074443898,0,0,0,0,0,0,0,0,0.320568492303233 | |||
|short_description=p@chr17:6745896..6745904,- | |||
}} |
Latest revision as of 20:21, 25 July 2015
Short description: | p@chr17:6745896..6745904, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr17:6745896..6745904, - |
Coexpression cluster: | C110_leukemia_chronic_Eosinophils_acute_Whole_CD34_Lymphatic |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
myeloid cell | 1.35e-09 | 108 |
common myeloid progenitor | 1.35e-09 | 108 |
mast cell | 6.77e-07 | 5 |
basophil mast progenitor cell | 6.77e-07 | 5 |
Ontology term | p-value | n |
---|---|---|
chronic leukemia | 1.42e-32 | 8 |
chronic myeloid leukemia | 1.33e-29 | 1 |
cystadenocarcinoma | 3.16e-29 | 1 |
mucinous cystadenocarcinoma | 3.16e-29 | 1 |
myeloid leukemia | 3.34e-23 | 31 |
leukemia | 1.54e-18 | 39 |
hematologic cancer | 2.83e-14 | 51 |
immune system cancer | 2.83e-14 | 51 |